Surgery – Means for introducing or removing material from body for... – Treating material introduced into or removed from body...
Patent
1998-12-23
2000-11-21
Bockelman, Mark
Surgery
Means for introducing or removing material from body for...
Treating material introduced into or removed from body...
604507, 60410301, 60410302, 623 1, A61N 130
Patent
active
061496413
ABSTRACT:
A method for inducing angiogenesis in blood vessels proximal to ischemic tissue or proximal to stenosed regions including application of an estrogen compound to the blood vessel walls at a treatment site proximal to or upstream of the stenosis. A preferred delivery device is a double walled drug delivery catheter having porous outer walls. Another suitable delivery device is a drug injection device for injecting angiogenic material into blood vessel walls. One delivery method utilizes iontophoresis.
REFERENCES:
patent: 5180366 (1993-01-01), Woods
patent: 5219739 (1993-06-01), Tischer et al.
patent: 5295962 (1994-03-01), Crocker et al.
patent: 5300679 (1994-04-01), Baylis et al.
patent: 5376652 (1994-12-01), Javitt
patent: 5389314 (1995-02-01), Wang
patent: 5395831 (1995-03-01), Gemmill, Jr. et al.
patent: 5425703 (1995-06-01), Feiring
patent: 5437864 (1995-08-01), Edgington et al.
patent: 5457113 (1995-10-01), Cullinan et al.
patent: 5462937 (1995-10-01), Cullinan et al.
patent: 5472985 (1995-12-01), Grainger et al.
patent: 5492926 (1996-02-01), Cullinan et al.
patent: 5516528 (1996-05-01), Hughes et al.
patent: 5538504 (1996-07-01), Linden et al.
patent: 5545569 (1996-08-01), Grainger et al.
patent: 5552395 (1996-09-01), Gemmill, Jr. et al.
patent: 5554119 (1996-09-01), Harrison et al.
patent: 5567828 (1996-10-01), Dodge
patent: 5580569 (1996-12-01), Giampapa
patent: 5580722 (1996-12-01), Foulkes et al.
patent: 5591129 (1997-01-01), Shoup et al.
patent: 5882334 (1999-03-01), Sepetka
patent: 6045565 (2000-04-01), Ellis et al.
Hyder, et al., "Triphenylethylene Antiestrogens Induce Uterine Vascular Endothelial Growth Factor Expression Via Their Partial Estrogen Agonist Activity," Cancer Lett. (Shannon, Irel.), 120 (2), pp. 165-171 (1997). (Abstract).
Morales, et al., "Estrogen Promotes Angiogenic Activity In Human Umbilical Vein Endotheilal Cells in Vitro And In A Murine Model," Circulation, 91 (3), pp. 755-763 (1995). (Abstract).
Textbook of Biochemistry with Clinical Correlations, Edited by Thomas M. Devlin, PhD., Wiley-Liss Publications, Copyright 1992, p. 921.
The Encyclopedia of Molecular Biology, Sir John Kendrew, Blackwall Science, Copyright 1994, p. 1112.
Bruengger et al., "Smooth Muscle Cell of the Canine Prostate in Spontaneous Benign Hyperplasia, Steroid Induced Hyperplasia and Estrogen of Tamoxifen Treated Dogs", The Journal of Urology, vol. 130, Dec. 1983, pp. 1208-1210.
Schwartz et al., "Nicotinic Cholinergic Receptor Binding Sites in the Brain: Regulation in vivo", Science, vol. 220, No. 4593, Apr. 1983, pp. 214-216.
Bockelman Mark
Sci-Med Life Systems, Inc.
LandOfFree
Local delivery of estrogen for angiogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Local delivery of estrogen for angiogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Local delivery of estrogen for angiogenesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1252902